Suppr超能文献

n-3多不饱和脂肪酸(鱼油)在肠内营养中的应用。

The use of n-3 PUFAs (fish oil) in enteral nutrition.

作者信息

Gerster H

机构信息

Vitamin Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland.

出版信息

Int J Vitam Nutr Res. 1995;65(1):3-20.

PMID:7657477
Abstract

Severely ill patients in need of enteral nutrition support must obtain all essential nutrients in at least the amounts recommended for daily intake (RDA) by healthy populations. Until recently essential fatty acids have been entirely omitted from enteral solutions or included only in the form of n-6 PUFAs which are structurally important for cell membranes and play a significant role as precursors (esp. arachidonic acid, AA) of eicosanoids (prostaglandins, thromboxanes, leukotrienes). However, in the absence of n-3 PUFAs, these eicosanoids may produce exaggerated effects in acute stress responses causing immunosuppression, platelet aggregation and excessive or chronic inflammation. n-3 PUFAs act as precursors of complementary eicosanoids which counteract the exaggerated responses of AA-derived eicosanoids. Therefore, n-3 PUFAs should be part of any optimally balanced diet and must be included also in enteral solutions. Since the transformation of the n-3 parent fatty acid, alpha-linolenic acid, to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) is slow and unreliable, it is necessary to provide them as preformed nutrients as they occur in fish oil. The British Nutrition Foundation recommends a daily intake of EPA and DHA in amounts corresponding to the intake of 3 to 4 g standardized fish oil. The requirements can also be covered by the weekly consumption of 2 to 3 portions of fatty fish. Preliminary clinical trials have shown certain beneficial effects of fish oil intakes in diseases associated with inflammatory reactions such as rheumatoid arthritis or inflammatory bowel disease, in conditions with impaired immune competence such as burns, post-operative situations and cyclosporine treatment after renal transplants, and in conditions with enhanced platelet aggregation such as after coronary angioplasty. While these findings must be verified in strictly controlled trials, the intake of fish oil n-3 PUFAs in a balanced ratio to n-6 PUFAs can be recommended for all patients including those in need of enteral nutrition support.

摘要

需要肠内营养支持的重症患者必须获取所有必需营养素,且其摄入量至少要达到健康人群推荐的每日摄入量(RDA)。直到最近,肠内营养制剂中仍完全不含必需脂肪酸,或仅含有n-6多不饱和脂肪酸(PUFA)形式,这些脂肪酸对细胞膜结构很重要,并且作为类二十烷酸(前列腺素、血栓素、白三烯)的前体(尤其是花生四烯酸,AA)发挥重要作用。然而,在缺乏n-3多不饱和脂肪酸的情况下,这些类二十烷酸在急性应激反应中可能会产生过度作用,导致免疫抑制、血小板聚集以及过度或慢性炎症。n-3多不饱和脂肪酸作为互补类二十烷酸的前体,可抵消源自花生四烯酸的类二十烷酸的过度反应。因此,n-3多不饱和脂肪酸应成为任何最佳平衡饮食的一部分,也必须包含在肠内营养制剂中。由于n-3母体脂肪酸α-亚麻酸转化为二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)的过程缓慢且不可靠,因此有必要将它们作为鱼油中所含的预制营养素来提供。英国营养基金会建议,EPA和DHA的每日摄入量应相当于摄入3至4克标准鱼油。每周食用2至3份富含脂肪的鱼类也可满足这些需求。初步临床试验表明,摄入鱼油对与炎症反应相关的疾病(如类风湿性关节炎或炎症性肠病)、免疫功能受损的情况(如烧伤、术后情况以及肾移植后的环孢素治疗)以及血小板聚集增强的情况(如冠状动脉血管成形术后)具有一定的有益作用。虽然这些发现必须在严格对照试验中得到验证,但对于所有患者,包括需要肠内营养支持的患者,建议以与n-6多不饱和脂肪酸保持平衡比例的方式摄入鱼油n-3多不饱和脂肪酸。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验